Lactobacillus sporogenes was isolated from green malt in 1949, by Japanese researchers, and was later reclassified as Bacillus coagulans. Bacillus coagulans (marketed as Lactospore®) is a shelf stable (at room temperature) probiotic, with clinically documented efficacy in supporting health and wellness.

Lactospore works on restoring gastrointestinal balance through competitive inhibition of pathogens, the production of L-(+) lactic acid and hydrogen peroxide, and production of bacteriocins, a sort of natural antibiotic that suppresses the growth of putrefactive bacteria.

Being in spore form, this culture survives and proliferates in the gastrointestinal environment more easily than most other probiotics. Lactospore also produces only the beneficial L-(+) form of lactic acid in the gastrointestinal tract, unlike some other probiotics that also produce D-(-) form of lactic acid, which has been associated with metabolic acidosis.

Clinical efficacy of Lactospore has been shown in the management of gastrointestinal problems associated with infections, or the use of antibiotics. Conditions include diarrheal diseases and constipation, as studied in populations of all ages, including infants, and promising results in the management of allergic skin diseases (eczema) in infants, were observed.

Benefits:

• Lactospore restores gastrointestinal balance through inhibiting pathogens and encouraging good bacteria to thrive.
  • Clinically effective in the management of gastrointestinal problems associated with infections, or the use of antibiotics.
  • Proven value in the treatment of diarrheal diseases, and constipation, in populations of all ages.
  • Stable at room temperature, naturally resistant to stomach acid.